REGN4461: Clinical Trials

3 trials of REGN4461, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting, 1 terminated. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 1, Recruiting 1, Terminated 1

Follow REGN4461: new trials by email Literature Review of REGN4461 trials Research Report on REGN4461

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Investigate Mibavademab in Adult Women With Functional Hypothalamic Amenorrhea
Mibavademab, Placebo - Functional Hypothalamic Amenorrhea, FHA
Phase 2RecruitingRegeneron Pharmaceuticals342026-03-112026-11-04
A Study of Tirzepatide (LY3298176) Plus Mibavademab Compared With Tirzepatide Alone in Adult Participants With Obesity
Tirzepatide, Mibavademab, Tirzepatide-Placebo - Obesity
Phase 2CompletedEli Lilly and Company3922024-04-242026-05-06
A Study to Examine the Effects of the Leptin Receptor (LEPR) Agonist Antibody REGN4461 in Adult Patients With Familial Partial Lipodystrophy (FPLD)
REGN4461, Matching Placebo - Familial Partial Lipodystrophy, Metabolic Abnormalities
Phase 2TerminatedRegeneron Pharmaceuticals202022-02-282025-10-16

Conditions studied

Amenorrhea (1)  ·  Infertility, Female (1)  ·  Lipodystrophy, Familial Partial (1)  ·  Obesity (1)

Sponsors

Regeneron Pharmaceuticals (2)  ·  Eli Lilly and Company (1)

Countries

United States (3)  ·  France (1)  ·  Spain (1)  ·  Turkey (Türkiye) (1)